Featured on Endpoints News: Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

AbCellera’s antibody discovery platform is being mobilized to accelerate preclinical development of biologics alongside Boston biotech startup Invetx. In collaboration with AbCellera, the company is working on leveraging the success of monoclonal antibodies in humans to treat chronic diseases in animals.


Read full coverage on Endpoints News.


Together we can make game-changing discoveries.